CBD or cannabidiol is one of the main organic compounds naturally produced by the cannabis plant, and is normally extracted from hemp. It is one of more than 100 cannabinoids identified in cannabis and one of the most abundant. CBD is a safe, non-intoxicating, non-addictive substance that has been proven to have numerous benefits for human health.

Satbis CBD oils are produced in the European Union following strict quality control standards. The plants are organically grown, tested by independent laboratories and guaranteed free of contaminants. The extracts are obtained through a CO2 extraction method, which preserves all the plant's active ingredients without leaving any harmful products behind. As a carrier oil, we use MCT oil obtained from coconuts, which increases the bioavailability of CBD. In addition to product quality, Satbis guarantees its customers attentive and personalized support.

CBD has been the subject of study due to its potential effects on reducing anxiety. Research suggests that CBD may play a role in reducing anxiety about specific situations, such as public speaking, which may be relevant for patients facing challenges related to social anxiety. Study results indicate that CBD may have significant anxiolytic effects, offering a promising approach to managing anxiety.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079847/

CBD oil is an extract made from a plant rich in CBD. There are several types of CBD oils. As a general rule, when we talk about CBD oil we are referring to an extract of hemp flowers with a high concentration of cannabinoids, with CBD being the most concentrated cannabinoid, diluted in a carrier oil (for example coconut oil, seed oil hemp, olive oil). In the case of Satbis, CBD oil consists of a Full Spectrum hemp extract diluted in MCT oil derived from coconut. CBD oil is known for its potential beneficial and therapeutic effects, such as reducing anxiety, relieving pain, and treating specific medical conditions.

There is evidence to suggest that CBD may help with sleep. CBD has calming and relaxing properties, which can promote a feeling of tranquility and help alleviate anxiety, one of the main factors that can interfere with sleep. Additionally, studies indicate that CBD can help regulate the sleep cycle, improving the quality and duration of sleep. However, it is important to remember that each person is unique and their experience with CBD may vary. It is recommended to consult a healthcare professional before starting to use CBD products for proper guidance.

https://pubmed.ncbi.nlm.nih.gov/28349316/

https://journals.lww.com/clinicalneuropharm/abstract/2022/03000/clinical_management_of_sleep_and_sleep_disorders.3.aspx

The endocannabinoid system is a complex cell signaling system found in the human body and other animals. It plays a crucial role in regulating a number of physiological processes such as sleep, appetite, mood, pain and immune response. The endocannabinoid system is made up of cannabinoid receptors, such as CB1 and CB2 receptors, and endocannabinoids, such as anandamide and 2-AG, which are substances produced by the body itself. The activation of these receptors by the endocannabinoid system helps maintain the body's internal balance, known as homeostasis.

CBD has been the subject of study due to its potential effects in the treatment of Crohn's Disease. Research suggests that cannabinoids, including CBD, may play an important role in reducing inflammation and relieving symptoms associated with Crohn's disease. The results of the meta-analysis and systematic review indicate that the use of cannabinoids is associated with a statistically significant improvement in the induction and maintenance of clinical remission in patients with Crohn's Disease. These findings support the therapeutic potential of cannabinoids, including CBD, as a treatment option for Crohn's Disease. However, it is important to note that more research is needed to confirm the effectiveness and safety of CBD in treating this condition, and its use should be approached with caution and under the guidance of a qualified healthcare professional.

https://www.tandfonline.com/doi/full/10.1080/17474124.2020.1740590

Terpenes are organic compounds that can be found in plants. Terpenes are responsible for the characteristic aromas and flavors of different cannabis strains. Furthermore, terpenes may also have therapeutic properties, such as relaxing, anti-inflammatory or stimulant effects. Some common terpenes found in the cannabis plant are myrcene, limonene, pinene, and linalool.

According to preliminary research, CBD (cannabidiol) may be safe and beneficial for pets such as dogs and cats. Just like in humans, CBD interacts with the endocannabinoid system in animals and can help reduce pain, anxiety, inflammation and seizures. However, it is important to highlight that each animal is unique and may react differently to CBD. It is recommended to consult a veterinarian before administering CBD to your pets to ensure proper dosage and avoid interactions with other medications.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003882/

One area where CBD has shown promise is in multiple sclerosis (MS), a chronic disease of the central nervous system that can lead to debilitating symptoms.

Research suggests that CBD may have anti-inflammatory and neuroprotective properties that may be beneficial for people with multiple sclerosis. Clinical studies have shown that CBD can help reduce inflammation associated with multiple sclerosis, decrease pain related to the disease, and improve patients' quality of life.

Additionally, CBD can also help control muscle spasms, one of the common symptoms of MS. Studies have shown that CBD can reduce the intensity and frequency of these spasms, providing relief to patients.

https://pubmed.ncbi.nlm.nih.gov/35510826/

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013444.pub2/full

CBD has been the subject of study due to its potential effects in the treatment of epilepsy. Research suggests that CBD may be effective in reducing the frequency and severity of epileptic seizures in patients with refractory epilepsy. A double-blind randomized clinical trial demonstrated that CBD was associated with a significant reduction in the frequency of seizures in patients. CBD has generated a great deal of interest as a potential treatment for epilepsy. Studies and clinical reports have suggested that CBD may help reduce the frequency and severity of epileptic seizures in patients, especially children with rare and severe forms of the condition. For example, a study published in the New England Journal of Medicine showed that CBD was effective in reducing seizures in children with Dravet syndrome, a rare and severe form of epilepsy. Furthermore, CBD has been used in combination with other treatments, such as conventional anti-epileptic medications, and has shown significant benefits in controlling epileptic seizures. However, it is important to note that the use of CBD to treat epilepsy should be supervised by a healthcare professional, as side effects may occur and the recommended dosage varies depending on several individual factors. Therefore, CBD holds promising potential as a complementary treatment option for patients suffering from epilepsy, but its use must be carefully evaluated and monitored by qualified healthcare professionals.

https://www.researchgate.net/publication/368879679_Guia_pratico_para_profissionais_de_saude_e_Monografia_Thronus_Medical

Cannabidiol (CBD) has been the subject of study for the treatment of joint pain, such as pain associated with osteoarthritis. A study in rats demonstrated that CBD can mitigate early inflammation, preventing pain and nerve damage associated with osteoarthritis. Furthermore, the therapeutic potential of cannabinoids, including CBD, in controlling chronic pain has been explored, with evidence of analgesic effects and reduced opioid use in some cases. One study investigated the use of CBD in treating arthritis and joint pain, suggesting potential benefits in reducing pain and improving quality of life.

https://pubmed.ncbi.nlm.nih.gov/35999581/
https://pubmed.ncbi.nlm.nih.gov/28885454/

There are no official dosage guidelines for using CBD. Experts recommend starting with a low dose of around 10-20 mg per day and increasing by 5-10 mg until you reach the most effective dose. For some, much higher doses of around 100-200 mg per day may be necessary. It is best to start with a low dose, monitor the effects for a week before increasing. The effects of CBD are cumulative and take time to develop. Finding the ideal dose requires patience. It is recommended that you consult a doctor experienced in the use of CBD. Although CBD is well tolerated, side effects such as drowsiness may occur at higher doses. Starting slowly helps minimize side effects. Consistency is key – CBD works best when taken daily at regular intervals.